Elevation Point Wealth Partners LLC acquired a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,146 shares of the conglomerate’s stock, valued at approximately $2,127,000.
A number of other hedge funds also recently made changes to their positions in DHR. Main Street Group LTD acquired a new position in shares of Danaher during the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC acquired a new stake in Danaher during the 2nd quarter valued at $25,000. JPL Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter valued at $25,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter worth $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher during the fourth quarter worth $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Stock Up 0.3%
DHR opened at $219.42 on Monday. The stock has a fifty day moving average of $195.80 and a 200-day moving average of $192.40. The company has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on DHR. Royal Bank Of Canada increased their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. DZ Bank assumed coverage on shares of Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price for the company. Citigroup started coverage on shares of Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. Piper Sandler initiated coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. Finally, TD Cowen reduced their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $228.91.
View Our Latest Research Report on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
